<DOC>
	<DOCNO>NCT01766752</DOCNO>
	<brief_summary>Objective : To investigate performance ( safety ) GlucoTab system glycaemic management non-critically ill patient type 2 diabetes general ward</brief_summary>
	<brief_title>Performance Tablet Based Workflow Decision Support System With Incorporated Software Algorithm Used Glycaemic Management</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Informed consent obtain advised nature study Male female age 18 90 year ( inclusive ) Type 2 diabetes treat diet , oral agent , noninsulin inject antidiabetic medicine , insulin therapy combination four Impaired renal function ( serum creatinine â‰¥3.0mg/dL ) Any disease condition investigator treat physician feel would interfere trial safety patient Pregnancy Any mental condition render patient incapable give consent Terminally ill patient Participation trial within 3 month prior trial Known suspect allergy insulin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>